Rajendra Singh, MD
Disclosures: Nothing to disclose
Raj Singh CV

RAJENDRA S.SINGH, MD

 

 

 

RAJENDRA S.SINGH, M.D.

Rajendra.singh@mountsinai.org

 

 

 

ACADEMIC APPOINTMENTS

 

2011-present              Associate Professor of Pathology and Dermatology

Associate Director, Dermatopathology Section

Dermatopathology Fellowship Program Director

                        Icahn School of Medicine at Mount Sinai, New York, NY

 

2010-2011              Assistant Professor of Pathology and Dermatology

                        University of Pittsburgh Medical Center, Pittsburgh, PA

 

 

 

HOSPITAL APPOINTMENTS

 

2011-present              Attending Pathologist, Division of Dermatopathology

              Department of Pathology, The Mount Sinai Hospital, New York, NY

 

2017-2022                  Visiting Professor, Sree Balaji Medical College and Hospital, Bharath University, Chennai, India

 

2010-2011              Attending Pathologist, Department of Pathology

              University of Pittsburgh Medical Center, Pittsburgh, PA

 

2006-2007              Clinical Fellow, Department of Pathology

              M. D. Anderson Cancer Center, Houston, TX

 

2003-2006              Clinical Associate, Department of Pathology and Laboratory Medicine

              Wayne State University, Detroit, MI

 

2002-2003              Post-Doctoral Fellow (Mentor: Dr. W.Grizzle), Department of Pathology, University of Alabama at Birmingham, Birmingham, AL

 

1997-2001              Chief Pathologist, Jay Pathology Laboratories, Baroda, India

 

1995-1997              Instructor, Blood Bank Director, Department of Pathology, M.S.University, Baroda,

                        India

 

 

 

 

 

HEALTHCARE INDUSTRY APPOINTMENTS

 

 

2017-2020              Editorial Board Member

              WHO Classification of Tumors 5th Edition

 

 

2007-2010              Senior Staff Pathologist

                        Quest Diagnostics, Teterboro, NJ

 

 

GAPS IN EMPLOYMENT

None

 

 

EDUCATION & TRAINING

 

2006-2007              Fellowship in Dermatopathology (Mentor: Victor Prieto, M.D.)

              Department of Pathology, M.D.Anderson Cancer Center, Houston, TX

 

2003-2006              Residency in Anatomic Pathology

              Department of Pathology and Laboratory Medicine,

              Wayne State University, Detroit, MI

 

1992-1995              Resident in Anatomic and Clinical Pathology (MD)

       Maharaja Sayajirao University, Baroda Medical College, Baroda, India.

1986-1991               Medical Student (MBBS) M.S.University, Baroda Medical College, Baroda, India.

 

 

CERTIFICATION

 

2006-2022              Board eligible-Clinical Informatics

2006-2026              Diplomate in Anatomic Pathology, American Board of Pathology (#06-032)

2006-2026       Diplomate in Dermatopathology, American Board of Pathology (#S-07-185)

2003                Diplomate, National Board of Medical Examiners (USMLE 1, 2, 3: #0-559-525-1)

1995                MD in Anatomic and Clinical Pathology, Indian Board of Pathology

1991              MBBS, Indian Medical Board

 

 

LICENSURE

 

2011-2019              Medicine License, State of New York (#259866-1)

2007-2019              Medicine License, Sate of New Jersey (#NJ 25M408257500)

2010-2012       Medicine License, State of Pennsylvania (#MD 440543)

 

 

 

HONORS & AWARDS

 

2018                            Teaching Excellence Award, Dermatology, Mt. Sinai School of Medicine             

2017                            Teaching Excellence Award, Dermatology, Mt. Sinai School of Medicine

2016                         Teaching Excellence Award, Dermatology, Mt. Sinai School of Medicine

2015                         Mentor Par Excellence, Dermatology, Mt. Sinai School of Medicine

2013              Exceptional Achievement by Faculty Member, Pathology, Mt. Sinai School of Medicine

2013                         Teaching Excellence Award, Dermatology, Mt. Sinai School of Medicine

2012                         Teacher of the Year Award, Dermatology, Mt. Sinai School of Medicine

2011                         Appointed for Best Teacher Award, Pathology, UPMC

 

 

 

OTHER PROFESSIONAL APPOINTMENTS

 

2008-2009              Quality Control Leader, Quest Diagnostics, Teterboro, NJ

2009-present              Manuscript Reviewer, Journal of Cutaneous Pathology

2009-present              Manuscript Reviewer, Histopathology

2009-present              Manuscript Reviewer, Indian Journal of Dermatology and Venerology

2009-present              Manuscript Reviewer, Pathology Research International

2016-present              Section Editor, Digital Pathology, Journal of Clinical Pathology

2016-present              Section Editor, Digital Pathology, American Society of Dermatopathology

 

RESEARCH PROFILE

 

My research interests are in molecular profiling of melanocytic lesions and the use of artificial intelligence and deep learning in digital pathology. With respect to melanoma research, I started as a fellow at M.D. Anderson Cancer Center, where I was involved with grant writing and a research project on the genetic features of ulcerated melanomas (those with poor prognosis) with my mentor, Dr. Prieto. The grant was approved by the Melanoma Tumor Board and research presented at the annual meeting of The ASDP. As a researcher at Pittsburgh Medical Center and Mt. Sinai, I was involved in the study of histone variant H2A.Z.2 in melanomas and its role in proliferation and drug sensitivity and how SIRT6 haploinsufficiency induces BRAF V600E melanoma cell resistance to MAPK signaling inhibitors via IGFBP2 with Dr. Emily Bernstein; results were published in Molecular Cell and submitted in another paper to Nature Medicine. In other studies, I researched the role of BRAF mutations and its association with prognostic features of melanoma with Dr. Mahalingam of Boston University, results published in Human Pathology and Histopathology. We also investigated the role of NFI, TERT1 and PDLI1 in desmoplastic melanomas, all of which has been published. Regarding digital pathology, I have collaboration with CMU and Wake Forest researchers, in which we analyzed the use of software and optics of digital imaging to distinguish melanomas from benign lesions. The study was published along with another review in journals. Presently we are investigating deep learning techniques in identifying mutations in melanomas from histology patterns.

 

 

 

 

CLINICAL PROFILE

 

I am actively involved in clinical dermatopathology cases at Mt. Sinai. I personally sign out approximately 300-400 cases a week. These cases encompass the entire gamut of dermatology and range from rashes to benign and malignant neoplasms. Although all cases are clinically important, we see a large number of melanomas, sarcomas and lymphomas which have a significant impact on patients’ lives. These cases are carefully worked up with histological and immunohistochemistry stains as well as molecular tests. Mt. Sinai is a tertiary institution and patients and clinicians expect reports that are of the highest quality and provide all information that will be needed to treat these complex cases. Cases seen in my section are not only from Mt. Sinai, but from the tristate area and across the country. When needed, I discuss cases with clinicians in tumor boards regarding the best possible treatment options for our patients. I also present data collected from our large patient base in various national meetings so that other clinicians may learn from our experiences at Mt. Sinai.  During my sign out sessions, fellows and residents in training are present for one-on-one teaching which greatly impacts the future of our junior physicians and helps them treat patients more effectively. As such, I have been voted as one of the best teachers by our trainees almost every year for the past six years. I also continue to be a consultant for my previous departments in both Pittsburgh and India, who send digitalized cases for expert review.

 

 

 

 

IMPACT

 

As a researcher, I have made significant contributions in understanding molecular and genomic alterations in melanoma biology and treatment. I have been a pioneer in the use of artificial intelligence and deep learning technology to help make a better diagnosis. The quantification of nuclear chromatin using just pixel data and software programs is now being used for many other tumor types at multiple institutions. My app, mydermpath which is now taken over by the American academy of dermatology is the most downloaded app of the AAD and is being used by trainees around the world to enhance their knowledge of dermatology and dermatopathology. I have helped significantly in building the education platform, PathPresenter.net. This platform is now being used in 148 countries by pathologists, pathology departments and other clinicians to enhance their knowledge in every specialty of pathology as well as share cases with each other. I am part of a select group of pathologists from around the world that form the Editorial Board of the WHO Classification of Tumors. As a member of this elite group, I am helping in shaping the new classification of tumors along with providing content to the Blue Books, which are used by every pathologists and oncologists in the world for tumor classification and management. I am also the lead for helping the WHO in going digital and using technology to spread knowledge. As a Pathology Informacist, I speak and chair at national and international meetings and help shape the introduction of digital pathology in practice, education and research.

 

 

 

 

 

 

 

 

 

 

GRANTS, CONTRACTS, FOUNDATION SUPPORT

 

PAST GRANTS

 

FUNDING SOURCE

ROLE

DATES

DIRECT COSTS

SUPPLEME-NTAL INFO

NIH Skin/ SPORE/ M.D.Anderson Cancer Center Core Committee.          STUDY: Why do ulcerated melanomas have a worse prognosis? An analysis of their gene expression profiles and microvascular density (angiogenesis) compared with non-ulcerated melanomas.

 

 

 

 

 

 

 

 

American Academy of Dermatology-Sulzberger Foundation                               PROJECT: Teaching tools for dermatology and dermatopathology in the 21st century.

CO-INVESTIGATOR-I designed the study and wrote the manuscript for the grant. I collected all the cases of ulcerated and non-ulcerated melanomas, and performed gene expression profiles of the same. The findings were presented at the Annual American Society of Dermatopathology meeting as a platform presentation.

 

PRINCIPAL INVESTIGATOR           I wrote the entire subject matter of dermatopathology and dermatology along with algorithms for histological diagnosis, immunohistochemistry and immunofluorescence. This material was then converted into an app with collaboration of software engineers and provided as a free educational tool on iTunes and Android platform. The information was also developed for desktops in the form of a website.

Sep 2006-Mar 2007

 

 

 

 

 

 

 

 

 

 

 

 

 

 

July 2013-June 2014

N/A-was a fellow

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5 percent

N/A

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

N/A

 

 

 

 

 

 

 

 

 

 

 

CURRENT GRANTS

 

FUNDING SOURCE

ROLE

DATES

DIRECT COSTS

SUPPLEME-NTAL INFO

Derm Sciences (GCO# 13-1507)

Honey Dressing for Local Wound Care of Split Thickness Skin Graft and Free Tissue Transfer Donor Sites:  A Prospective Randomized Controlled Trial

Co-Investigator                I will be reviewing the slides pre and post study to look for effects on wound healing.

July 2015-June 2018

N/A

N/A

 

In the above, I function as the study Pathologist in terms of coordinating histological data accrual and interpretation, correlation with histological findings, and providing scientific and academic support in the preparation, authoring and editing of related manuscripts.

 

SUBMITTED GRANTS:

 

 

  1. Rajendra Singh, Gustavo Rhodes.  Image analysis and machine learning based algorithms of virtual slides for accurate diagnosis and classification of melanocytic lesions. Melanoma Research Alliance

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TRAINEES

 

 

 

NAME

LEVEL OF TRAINEE

ROLE IN TRAINING

TRAINING VENUE

TRAINEES’ CURRENT EMPLOYEMENT

AGAR BEFGHOFF

Dermatopathology Fellow

Attending 2010-June 2011

University of Pittsburgh Medical Center

Private Practice –Atlanta, GA

JAMES EDINGER

Dermatopathology Fellow

Attending

October 2010-June 2011

University of Pittsburgh Medical Center

University of Missouri-Columbia, School of Medicine, Dept. of Pathology, Clinical Assistant Professor,

SHERRY VARGHESE

Dermatopathology Fellow

Attending

July 2011-October 2011

University of Pittsburgh Medical Center

Private Practice-Florida

JOHN VU

Dermatopathology Fellow

Attending

July 2011-October 2011

University of Pittsburgh Medical Center

Private and Academic, University Of Maryland Medical Center. Baltimore,MD

HARLEEN SIDHU

Dermatopathology Fellow

Attending

November 2011-June 2013

Icahn School of Medicine at Mt. Sinai

Private Practice-Rochester, NY

JOHATHAN YAO

Dermatopathology Fellow

Attending

July 2013-June 2014

Icahn School of Medicine at Mt. Sinai

Further training at  UCLA

CHEN CHEN

Dermatopathology Fellow

Mentor

July 2014-2016

Icahn School of Medicine at Mt. Sinai

Private practice

DAVID TERANNO

Dermatopathology Fellow

Mentor

July 2016-2017

Icahn School of Medicine at Mt. Sinai

Private and Academic,

 

 

 

 

 

TEACHING ACTIVITIES

 

 

TEACHING ACTIVITY/TOPIC

LEVEL

ROLE

LEVEL AND NUMBER OF ATTENDEES

NUMBER OF HOURS

YEARS TAUGHT

Review Course of dermatopathology

Dermatology and Pathology Residents

Director

Residents(10-20)-Mt. Sinai

25 hours/year

2012-onwards

Journal Club

Dermatopathology Fellow and residents

Attending

Fellow and residents(2-10)-Mt. Sinai

20 hours/year

2012-onwards

Dermatopathology Conference

Residents

Lecturer

Residents(10-20)-Mt. Sinai and UPMC

40 hours/year

2010-onwards

 

 

 

 

ADMINISTRATIVE LEADERSHIP APPOINTMENTS (internal)

 

 

 

ADMINISTRATIVE LEADERSHIP APPOINTMENTS (internal)

 

2012-present              Member, Quality Assurance/Quality Control Committee,

                            Department of Pathology, Icahn School of Medicine at Mount Sinai

Committee in charge of identifying, monitoring, and trouble-shooting quality measures in the Department’s Medical School-associated operations.

 

2012-present              Member, Pathology Faculty Curriculum Review Group, Department of Pathology

                            Icahn School of Medicine at Mount Sinai

Part of an intradepartmental committee for the design and implementation of a new pathology training curriculum for Residents and Fellows.

 

2012-present    Reviewer and Member, Institutional Review Board

                            Icahn School of Medicine at Mount Sinai

Member of an institutional committee for the review of all studies being conducted at Mt. Sinai.

 

2012-present              Director, Immunodermatology

                            Department of Pathology, Icahn School of Medicine at Mount Sinai

 

Mt. Sinai is one of the few institutions in the tristate area that provide immunodermatology services. I run this service and we see around 300 cases a year.

 

2014-present              Dermatopathology Fellowship Program Director

                            Department of Pathology, Icahn School of Medicine at Mount Sinai

 

Duties include selection of new fellows for the program and working closely with ACGME to maintain program accreditation. Under my leadership we underwent a successful ACGME accreditation this year. Our program is now accredited for the next 10 years.

 

ADMINISTRATIVE LEADERSHIP APPOINTMENTS (national)

 

2014-2015              CHAIR, INFORMATICS COMMITTEE, AMERICAN SOCIETY OF DERMATOPATHOLOGY (ASDP)

 

The mission of this committee is as follows:

The ASDP Informatics Committee establishes and applies standards related to the organization, presentation, and delivery of electronic content. It provides direction for and facilitates all ASDP initiatives related to the Internet, including content management, technology, and resources, and it manages (designs, approves, coordinates, prioritizes, and monitors) ASDP Internet sites and resources consistent with direction from the ASDP Board.

 

Under my leadership the ASDP underwent a new website launch which runs efficiently on both desktops and mobile devices (mobile-responsive). A subcommittee was established for social media and our followers grew form less than 50 into the thousands. The ASDP slide library is now digitalized and vetting is being performed by members recruited by the committee.

 

2015-2016               MEMBER, AD HOC OVERSIGHT COMMITTEE

                            AMERICAN SOCIETY OF DERMATOPATHOLOGY

 

 

 

 

 

 

ADMINISTRATIVE LEADERSHIP APPOINTMENTS (international)

 

2017-2020              Editorial Board Member, WHO classification of tumors

 

This is a select group of 20 pathologists handpicked by the WHO from around the world, based on their expertise to guide the WHO with the Blue books. My role is to guide the WHO through its transition from paperback to digital format of all the Blue books in the upcoming 5th series. I will join the members of each Blue Book and help formulate their presentation format in 3-4 meetings every year at the WHO headquarters in Lyon, France.

 

 

 

 

PUBLICATIONS

 

Peer-Reviewed Original Contributions

 

 

  1. Singh RS, Craig MC, Jackson AB, Mountz JM. The predictive value of Alkaline Phosphatase and Creatine Phosphokinase in heterotopic ossification in patients of spinal cord injury. Arch Phys Med Rehabil. 2003 Nov; 84(11): 1584-8.
  2. Lonardo F,Singh R, Siddiq F, Pass H, Sheng S. Nuclear stain for maspin is linked to low

histological grade in pulmonary adenocarcinoma. Lung Cancer 2006 Jan; 51(1):31-9.

  1. Rajendra Singh , Olca Basturk , David S. Klimstra , Giuseppe Zamboni Runjan Chetty , Sanaa Hussain , Asli Yilmaz , Stefano La Rosa , Paola Capelli , Carlo Capella , Jeanette D. Cheng and N. Volkan Adsay. Lipid-Rich Variant of Pancreatic Endocrine Neoplasms. Am J Surg Pathol. 2006 Feb; 30(2):194-200.
  2. Rajendra S Singh, A. Hafeez Diwan and Victor G. Prieto. Potential diagnostic pitfalls in

melanoma arising in a cutaneous tattoo. Histopathology. 2007 Aug; 51(2):283-5.

  1. Rajendra S Singh, A. Hafeez Diwan, Peter S. Zhang and Victor G. Prieto. Phosphoinositide 3-kinase (PI3 Kinase) expression is not upregulated in melanoma progression.J Cutan Pathol. 2007 Mar; 34(3):220-5.
  2. Rosella Creed, Jenny Vu, Rajendra Singh, Dan Jones, Madeleine Duvic: Alopecia Areata preceding Mycosis Fungoides. The Internet Journal of Dermatology. 2007. Volume 5 Number 2.
  3. Vu, Jenny; Wallace, Genevieve R; Singh Rajendra, Diwan, Hafeez; Prieto, Victor; Rady Peter, Tyring, Stephen, Duvic, Madeleine. Common Variable Immunodeficiency Syndrome Associated with Epidermodysplasia Verruciformis. American Journal of Clinical Dermatology, Volume 8, Number 5, 2007, pp. 307-310(4).
  4. Singh RS, Bhattacharjee PB, Youngberg GA, Al-Abbadi MA. Sarcomatoid squamous cell carcinoma: a long-standing case. Acta Dermatovenerol Alp Panonica Adriat. 2008 Dec; 17(4):185-7.
  5. Singh RS, Grayson W, Redston M, Diwan AH, Warneke CL, McKee PH, Lev D, Lyle S,

Calonje E, Lazar AJF (2008) Site and Tumor Type Predicts DNA Mismatch Repair Status    in Cutaneous Sebaceous Neoplasia. Am J Surg Pathol. 2008 Jun;32(6):936-42.

  1. Basturk O, Singh R, Kaygusuz E, Balci S, Dursun N, Culhaci N, Adsay NV. GLUT-1 Expression in Pancreatic Neoplasia: Implications in Pathogenesis, Diagnosis, and Prognosis. Pancreas. 2011 Mar;40(2):187-92.
  2. Rajendra Singh, Liron Pantanowitz. Anil Parwani. Standirization Digital Pathology: Supplement 145 of the DICOM standards. J Pathol Inform. 2011; 2:23.
  3. Singh R, Chen, C., Phelps, R.G. and Elston, D.M. (2013), Stem cells in the skin and their role in oncogenesis. Journal of the European Academy of Dermatology and Venereology. 2014, May; 28(5):542-9.
  4. Chabra I, Singh R. Gouty tophi on the ear: a review. Cutis. 2013 Oct; 92(4):190-2.
  5. Aung PP, Leone D, Feller JK, Yang S, Hernandez M, Yaar R, Singh R, Helm T, Mahalingam M. Microvessel density, lymphovascular density, and lymphovascular invasion in primary cutaneous melanoma-correlation with histopathologic prognosticators and BRAF status.Hum Pathol. 2015 Feb;46(2):304-12.
  6. Chiara Vardabasso, Alexandre Gaspar-Maia, Dan Hasson1, Sebastian Pünzeler, David

Valle-Garcia1, Tobias Straub, Eva C. Keilhauer, Thomas Strub1, Joanna Dong, Taniya

Panda, Chi-Yeh Chung, Jonathan L. Yao, Rajendra Singh, Miguel F. Segura, Barbara

Fontanals-Cirera, Amit Verma, Matthias Mann, Eva Hernando, Sandra B. Hake, Emily

Bernstein. Histone variant H2A.Z.2 mediates proliferation and drug sensitivity of malignant melanoma. Mol Cell. 2015 Jul 2; 59(1):75-88.

  1. Jonathan Yao M, Joanna Dong B, James Strauchen M, Rajendra Singh. Blastic plasmacytoid dendritic (BPDN) neoplasm or BPDN-like lesion presenting after influenza vaccination and resolving with topical high potency steroid: A first report. JAAD Case Rep. 2015 Jun 13;1(4):203-6
  2. Matthew G Hanna, MD; Anil V Parwani, MD, PhD, Rajendra Singh, MD. "Smartphone Applications: A Contemporary Resource for Dermatopathology". J Pathol Inform. 2015 Jul 28;6:44.
  3. Julien Lanoue, BA; Rajendra Singh, MD; Chen Chen, MD; Robert Phelps.  Multiple Cutaneous Linear Neuromas. JAAD Case Rep. 2015 Aug 25;1(5):315-8.
  4. Noah Frydenlund, Phyu Phyu Aung, Dominick A Leone, John Kyle Feller, Shi Yang, Marier Hernandez, Ron Yaar, Rajendra Singh, Thomas Helm, Meera Mahalingam. BRAF status is an effect modifier in the relation between ulceration and lymphovascular invasion in primary cutaneous melanoma.

Submitted to Histopathology.

  1. Alexander Kadokura, BS,Noah Frydenlund, MS,Dominick A. Leone, MPH,Shi Yang, MD,Mai P. Hoang, MD, PhD,April Deng, MD, PhD,Marier Hernandez-Perez, MD,Asok Biswas, MD, FRCPath, DipRCPath,Rajendra Singh, MD, Ron Yaar, MD, PhD, Meera Mahalingam, MD, PhD, FRCPath. Neurofibromin protein loss in desmoplastic melanoma subtypes: implicating NF1 allelic loss as a distinct genetic driver? Hum Pathol. 2016 Jul;53:82-90
  2. Alexander Kadokura, BS,Noah Frydenlund, MS,Dominick A. Leone, MPH,Shi Yang, MD,Mai P. Hoang, MD, PhD,April Deng, MD, PhD,Marier Hernandez-Perez, MD,Asok Biswas, MD, FRCPath, DipRCPath,Rajendra Singh, MD, Ron Yaar, MD, PhD, Meera Mahalingam, MD, PhD, FRCPath.  Frequency of TERT promoter mutations in desmoplastic melanoma subtypes: analyses of 76 cases. Melanoma Res. 2016 Aug;26(4):361-6
  3. Matthew G. Hanna, MD; Chi Liu, PhD; Gustavo Rohde, PhD; Rajendra Singh, MD. Predictive Nuclear Chromatin Characteristics of Melanoma and Dysplastic Nevi. J Pathol Inform. 2017 Apr 10;8:15.
  4. Noah Frydenlund, Dominick Leone,hi Yang,Mai Hoang,April Deng,Marier Hernandez,Rajendra Singh, Asok Biswas. Tumoral PD-L1 expression in desmoplastic melanoma is associated with depth of invasion, tumor infiltrating CD8 cytotoxic lymphocytes and the mixed cytomorphologic variant. Mod Pathol. 2017 Mar;30(3):357-369
  5. Riana Dutt, Harold S. Rabinovitz,  Alon Scope, Rajendra Singh. Dermoscopic and confocal features of an axillary ‘special site’ nevus. Dermatol Pract Concept. 2017 Jan 31;7(1):55-58
  6. Thomas Strub, Flavia G. Ghiraldini, Saul Carcamo, Aleksandra Wroblewska, Man Li, Zichen Wang , Rajendra Singh, Matthew S. Goldberg , Dan Hasson, Stuart Gallagher, Peter Hersey, Avi Ma’Ayan, Georgina V. Long, Richard A. Scolyer, Bin Zheng , Brian Brown, and Emily Bernstein. SIRT6 haploinsufficiency induces BRAF V600E melanoma cell resistance to MAPK signaling inhibitors via IGFBP2.

Submitted to Nature Medicine

  1. Assessing the Predictive Value of Ki67 Staining in Melanocytic Lesions. Nikki Vyas, Garrett Desman, Rajendra Singh, Phelps Robert, McNiff  Jennifer.

Submitted to Journal of Cutaneous Pathology

  1. C. Liu, Y. Huang, J. A. Ozolek, M. Hanna, R. Singh and G. Rohde, "SetSVM: An Approach to Set Classification in Nuclei-based Cancer Detection," in IEEE Journal of Biomedical and Health Informatics, vol. PP, no. 99, pp. 1-1.
  2. Singh R, Teranno D. Unusual presentation of a skin rash. J Clin Pathol. 2017 Dec;70(12):1088

 

 

 

 

 

 

Book Chapters

 

2018                            Advanced Whole Slide Imaging: Current Applications and Future Directions

2018              Melanoma and other metastatic lesions: WHO blue book on Gastrointestinal Pathology

2018                            Adnexal tumors. WHO blue book on Skin Tumors

2012                            Chapter 1: Dermatology Review. CWS Review Book.

 

 

Non Peer-reviewed publications:

 

Mydermpath: An online resource that covers the entire subject matter of dermatopathology and dermatology. Covers more than a 1000 entities. Presently the most downloaded resource of the American Academy of Dermatology

 

Wiydx.com:  An online resource that covers the entire subject matter of dermatopathology . Covers more than a 1000 entities.

PathPresenter.net: An online resource that covers 15 sub specialties of pathology. Currently used by more than 30,000 users from 148 countries with 3000-5000 pageviews everyday. Covered extensively by various pathology journals and blogs.

 

 

 

INVITED LECTURES/PRESENTATIONS

 

10/2005              Phosphoinositide 3-Kinase (PI3Kinase) does not play a role in melanoma progression. American Society of Dermatopathology Annual meeting, Seattle, WA.

11/2007              Why do ulcerated melanomas have a worse prognosis? An analysis of their gene expression profiles and microvascular density (angiogenesis) compared with non-ulcerated melanomas. American Society of Dermatopathology Annual meeting, Washington DC.

04/2008              Problematic melanocytic lesions and their mimics. Department of Dermatology

University of Medicine and Dentistry of New Jersey, Newark, NJ.

06/2009              Recent perspectives in cutaneous neoplasms. Department of Dermatology

Jaslok Hospital, Mumbai, India.

01/2010              Interface Dermatitis. Annual meeting of Indian Association of Dermatologists. India

01/2011              Approach to cutaneous lymphomas. Oncopathology CME, Pune, India.

01/2011              Melanocytic Neoplasms. Tata Cancer Hospital, Mumbai, India.

10/2011              Faculty, Short Course in Teledermatopathology.ASDP Annual Meeting, Seattle, WA

03/2012              Faculty, Developing a new learning Tool for Dermatopathology.AAD Annual Meeting, San Diego, CA.

07/2012              MyDermPath- An interactive tool for teaching dermatopathology and dermatology.

Association of Professors in Dermatology meeting, Chicago, IL.

12/2012              Faculty, MyDermPath- An interactive tool for teaching dermatopathology and dermatology.15th Annual Winter Symposium, New York, NY.

08/2013              Guest Speaker. Dermatology practice in the Era of mobile devices.Indian Society of Teledermatology, Chennai, India.

10/2013              Guest Speaker. Teaching app developed via grant from Sulzberger Foundation, The American Society of Dermatopathology (ASDP) Dermatopathology Fellow Training Directors Meeting, Seattle, WA.

12/2013              Faculty, Infectious Diseases in Skin.16th Annual Winter Symposium, New York .

01/2014              Speaker and Faculty, Health Information Technology Workshop, Global Health Summit, Ahmedabad, India.

01/2104              Judge, Research Symposium, Global Health Summit, Ahmedabad, India.

02/2014              Guest Speaker. International Dermatology update. Chennai, India.

08/2014              CHAIRMAN, 5th World Congress of Teledermatology, Barcelona, Spain.

08/2014              Emerging Leaders in Dermatology 2014, New York Academy of Medicine. myDermPath - An interactive Comprehensive Resource for Dermatology and Dermatopathology. New York, NY.

12/2014              Faculty, What’s New in Dermatopathology.17th Annual Winter Symposium, New York, NY.

03/2015              Faculty, American Academy of Dermatology Annual meeting San Francisco.

06/2015              Faculty, Dermpathpro Board Review, Miami, Florida.

06/2015              Invited Speaker, Jag Bhawan Research Symposium, Boston University, Boston, MA.

08/2015              Invited Speaker, Indian Society of Teledermatology Annual Meeting, Chennai, India.

11/2015              Faculty, International Society of Dermatopathology Meeting, New Delhi, India.

12/2015              Faculty, What’s New in Dermatopathology.18th Annual Winter Symposium, New York, NY.

03/2016              Faculty, American Academy of Dermatology Annual meeting, Washington DC.

03/2016              Faculty, United States and Canadian Academy of Pathology Annual Meeting, Seattle, WA.

05/2016              Faculty, London Dermaopathology Symposium, London UK.

08/2016           Faculty, Asia Dermatology Congress, Mumbai, India

10/2016              Faculty, World Congress on Teledermatology, London, UK

12/2016              Faculty, Winter Symposium, New York, NY

03/2017              Faculty, AAD Annual Meeting, Orlando

03/2017              Faculty, United States and Canadian Academy of Pathology Annual Meeting, San Antonio, TX

04/2017              Faculty, Dermepedia Course on Soft Tissue Tumors

05/2017              Digital Pathology Symposium, Chicago, IL

08/2017              Faculty, AAD Summer Meeting, New York

08/2017              Chair and Faculty, Dermatopathology Review Course, Chennai, India

12/2017              Faculty, Winter Symposium, New York, NY

02/2018              Tri Con Digital Pathology Conference, San Francisco, CA

02/2018              Faculty, AAD Annual Meeting, San Diego, CA

04/2018              Faculty Dermpedia Course on Inflammatory Dermatopathology

06/2018              Chair, Digital Pathology Symposium, New York, NY

11/2018              Chair, World Teledermatology Conference, Houston, TX

11/2018              Grand rounds, MD Anderson Cancer Center, Houston, TX

12/2018              Faculty, Winter Sypmposium, New York, NY

01/2019              Faculty, GRIPE Annual meeting, New Orleans LA

04/2019              Speaker, Digital Pathology Congress, Japan

04/2019              Faculty, WHO Blue Book Companion meeting, Orlando, FL

05/2019              Faculty, Brazil Pathology Society Annual Meeting, Brazil

 

 

 

COURSE DIRECTOR

 

08/2015              Frontiers in Academic Pathology- Dermatopathology. New York Academy of Medicine New York, NY.

 

06/2016              The New York Dermpathology Review. New York, NY.

06/2017              The New York Dermpathology Review. New York, NY.

08/2017              Dematopathology review Course, Chennai, India

06/2018              The New York Dermpathology Review. New York, NY.

06/2019              The New York Dermpathology Review. New York, NY

 

 

 

 

 

MEDIA RESOURCE EDUCATIONAL MATERIAL

 

Editor-in-chief

Dermatopathology Slide Study set

UPMC, Pittsbugh, PA

Developed in 2010-2011.

This is a digital slide set with histories in a quiz format, developed for dermatology and pathology residents at UPMC.

 

 

 

 

 

MYDERMPATH APP (Will be released under AAD banner in August 2016)

 

Development took 4 years: 2009-2013.

Developer and author of the first app in dermatopathology, MyDermPath. This is a comprehensive review of the entire subject matter of dermatology and dermatopathology presented in an algorithmic format. In addition there are algorithms for immunohistochemistry, immunofluorescence and special stains. Describes normal skin histology and ultrastructure in a unique, animated format. Includes educational pop-quizzes and is accessible anytime, anywhere.

The app has been downloaded more than 10,000 times on iTunes and around 2000 times on Android from all over the world.

Intended users: Medical students, residents of dermatology and pathology, dermatology and pathology clinicians.

 

 

FOUNDER AND DEVELOPER

 

Mydermpath.com

An interactive website for teaching of dermatology and dermatopathology. Visits from more than 160 countries around the world.

Intended users: Medical students, residents of dermatology and pathology, dermatology and pathology clinicians.

 

WIYDX.COM

An interactive teaching website that showcases digital slides on every section of pathology.

 

 

PathPresenter.com

A platform for teaching and presentation in Pathology

 

 

 

 

 

CONFERENCE ABSTRACTS & PRESENTATIONS

 

Numerous (>25) platform and poster presentations (some with distinction or award-eligible) in national and international meetings, including the annual meetings of the following societies: American Academy of Dermatology (AAD), American Society of Dermatopathology (ASDP), American Association of Cancer Research (AACR) , Society of Nuclear Medicine (SNM), United States and Canadian Academy of Pathology (USCAP), International Society of Dermatopathology (ISDP).

 

PAST & PRESENT MEMBERSHIP IN PROFESSIONAL SOCIETIES

 

American Academy of Dermatology, American Society of Dermatopathology. International Society of Dermatopathology, College of American Pathologists, United States and Canadian Academy of Pathology.